Characteristics of selectors of nicotine replacement therapy

Tobacco Control

Volumn 14, Issue 5, 2005, Pages 346-355

  Shiffman, S ^a,b   Di Marino, M E ^a   Sweeney, C T ^a  

^a PINNEY ASSOCIATES   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE; NICOTINIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; FEMALE; HEALTH SURVEY; HUMAN; MALE; MENTAL DISEASE; METHODOLOGY; MIDDLE AGED; MOTIVATION; PATIENT ATTITUDE; PSYCHOLOGICAL ASPECT; PSYCHOMETRY; SMOKING; SMOKING CESSATION; SOCIOECONOMICS; TOBACCO DEPENDENCE;

ADOLESCENT; ADULT; AGED; ATTITUDE TO HEALTH; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; MOTIVATION; NICOTINE; NICOTINIC AGONISTS; PATIENT ACCEPTANCE OF HEALTH CARE; PSYCHOMETRICS; SMOKING; SMOKING CESSATION; SOCIOECONOMIC FACTORS; TOBACCO USE DISORDER;

EID: 25844502587     PISSN: 09644563     EISSN: None     Source Type: Journal    
DOI: 10.1136/tc.2004.009183     Document Type: Article

References (39)

1. Mokdad AH, Mark JS, Stroup DF, et al. Actual causes of death in the United States, 2000. JAMA 2004;291:1238-45.
2. Hughes JR, Keely J, Naud S. Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction 2004;99:29-38.
3. Fiore MC, Bailey WC, Cohen SJ, et al. Treating tobacco use and dependence. Clinical Practice Guideline. Rockville, Maryland: US Department of Health and Human Services, Public Health Service, 2000.
4. Shiffman S, Gitchell J, Pinney JM, et al. Public health benefit of over-the-counter nicotine medications. Tobacco Control 1997;6:306-10.
5. Burton SL, Gitchell JG, Shiffman S. Use of FDA-approved pharmacologic treatments for tobacco dependence - United States, 1984-1998. MMWR Morb Mortal Wkly Rep 2000;49:665-8.
6. Pierce JP, Gilpin EA. Impact of over-the-counter sales on effectiveness of pharmaceutical aids for smoking cessation. JAMA 2002;288:1260-4.
7. Cummings KM, Hyland A, Ockene JK, et al. Use of the nicotine skin patch by smokers in 20 communities in the United States, 1992-1993. Tobacco Control 1997;6:S63-70.
8. Heatherton TF, Kozlowski LT, Frecker RC, et al. Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day. Addiction 1989;84:791-800.
9. Shiffman S. Nicotine lozenge efficacy in light smokers. Drug Alcohol Depend 2005;77:311-14.
10. Shiffman S, Paton SM. Individual differences in smoking: gender and nicotine addiction. Nicotine Tob Res 1999;1(suppl 2):S153-7.
11. Shiffman S, Dresler CM, Hajek P, et al. Efficacy of a nicotine lozenge for smoking cessation. Arch Intern Med 2002;162:1267-76.
12. Silagy C, Lancaster T, Stead L, et al. Nicotine replacement therapy for smoking cessation (Cochrane Review). In: The Cochrane Library, Issue 1. Chichester, UK: John Wiley & Sons, Ltd, 2004.
13. White P, Watt J. Tobacco control in London: facts and issues. London: SomekeFree London, 2002.
14. Hymowitz N, Cummings KM, Hyland A, et al. Predictors of smoking cessation in a cohort of adult smokers followed for five years. Tobacco Control 1997;6:S57-62.
15. Nordstrom BL, Kinnunen T, Utman CH, et al. Predictors of continued smoking over 25 years of follow-up in the normative aging study. Am J Public Health 2000;90:404-6.
16. Pinto RP, Abrams DB, Monti PM, et al. Nicotine dependence and likelihood of quitting smoking. Addictive Behaviors 1987;12:371-4.
17. Hill HA, Schoenbach VJ, Kleinbaum DG, et al. A longitudinal analysis of predictors of quitting smoking among participants in a self-help intervention trial. Addictive Behaviors 1994;19:159-73.
18. Killen JD, Fortmann SP. Craving is associated with smoking relapse: findings from three prospective studies. Exp Clin Psychopharmacol 1997;5:137-42.
19. West RJ, Hajek P, Belcher M. Severity of withdrawal symptoms as a predictor of outcome of an attempt to quit smoking. Psychol Med 1989;19:981-5.
20. Stuart K, Borland R, McMurray N. Self-efficacy, health locus of control, and smoking cessation. Addictive Behaviors 1994;19:1-12.
21. Monso E, Campbell J, Tonnesen P, et al. Sociodemographic predictors of success in smoking intervention. Tobacco Control 2001;10:165-9.
22. Lasser K, Boyd JW, Woolhandler S, et al. Smoking and mental illness: A population-based prevalence study. JAMA 2000;284:2606-10.
23. National Center for Health Statistics. Dataset documentation, National Health Interview Survey, 1999. Hyattsville, Maryland: National Center for Health Statistics, 2002.
24. US Department of Labor, US Department of Commerce. Current Population Survey. Technical Paper 63. Design and Methodology. http:// www.census.gov/prod/ 2000pubs/tp63.pdf, 2000.
25. Heatherton TF, Kozlowski LT, Frecker RC, et al. The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom tolerance questionnaire. Br J Addiction 1991;86:1119-27.
26. Shiffman S, Waters A, Hickcox M. The nicotine dependence syndrome scale: a multidimensional measure of nicotine dependence. Nicotine Tob Res 2004;6:327-48.
27. Pierce JP, Cavin SW, Macky C, et al. Technical report on analytic methods and approaches used in the 1993 California tobacco survey analysis. Sacramento, California: California Department of Health Services, 1994.
28. Fagerstrom KO, Schneider NG. Measuring nicotine dependence: a review of the Fagerstrom tolerance questionnaire. J Behav Med 1989;12:159-82.
29. Matheny KB, Weatherman KE. Predictors of smoking cessation and maintenance. J Clin Psychol 1998;54:223-35.
30. Glassman AH, Helzer JE, Covey LS, et al. Smoking, smoking cessation, and major depression. JAMA 1990;264:1546-9.
31. Klungel OH, Martens EP, Psaty BM, et al. Methods to assess intended effects of drug treatment in observational studies are reviewed. J Clin Epidemiol 2004;57:1223-31.
32. Rockwood K, Kirkland S, Hogan DB, et al. Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people. Arch Neurol 2002;59:223-7.
33. Ness RB, Cauley JA. Antibiotics and breast cancer - what's the meaning of this? JAMA 2004;291:880-1.
34. Hughes JR, Shiffman S, Callas P, et al. A meta-analysis of the efficacy of over-the-counter nicotine replacement. Tobacco Control 2003;12:21-7.
35. Orleans CT, Resch N, Noll E, et al. Use of transdermal nicotine in a state-level prescription plan for the elderly. A first look at 'real-world' patch users. JAMA 1994;271:601-7.
36. Haxby D, Sinclair A, Eiff MP, et al. Characteristics and perceptions of nicotine patch users. J Family Pract 1994;38:459-64.
37. Johnson RE, Stevens VJ, Hollis JF, et al. Nicotine chewing gum use in the outpatient care setting. J Family Pract 1992;34:61-5.
38. Nides MA, Rakos RF, Gonzales D, et al. Predictors of initial smoking cessation and relapse through the first 2 years of the Lung Health Study. J Consult Clin Psychol 1995;63:60-9.
39. Zhu S, Melcer T, Sun J, et al. Smoking cessation with and without assistance: a population-based analysis. Am J Prev Med 2000;18:305-11.